Home
>
National Drug Code (NDC)
>
HALOPERIDOL
HALOPERIDOL - 0069-0113-02 - (HALOPERIDOL LACTATE)
Drug Information of HALOPERIDOL
| Product NDC: | 0069-0113 |
| Proprietary Name: | HALOPERIDOL |
| Non Proprietary Name: | HALOPERIDOL LACTATE |
| Active Ingredient(s): | 5 mg/mL & nbsp; HALOPERIDOL LACTATE |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HALOPERIDOL
| Product NDC: | 0069-0113 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078347 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110510 |
Package Information of HALOPERIDOL
| Package NDC: | 0069-0113-02 |
| Package Description: | 25 VIAL in 1 CARTON (0069-0113-02) > 1 mL in 1 VIAL (0069-0113-01) |
NDC Information of HALOPERIDOL
| NDC Code | 0069-0113-02 |
| Proprietary Name | HALOPERIDOL |
| Package Description | 25 VIAL in 1 CARTON (0069-0113-02) > 1 mL in 1 VIAL (0069-0113-01) |
| Product NDC | 0069-0113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HALOPERIDOL LACTATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20110510 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | HALOPERIDOL LACTATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |
